GERN
Geron Corp
Price:  
1.53 
USD
Volume:  
8,410,492.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN Relative Valuation

-252.4%
Upside

As of 2026-08-19, the Relative Valuation of Geron Corp (GERN) is (2.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.53 USD, the upside of Geron Corp based on Relative Valuation is -252.4%.

The range of the Relative Valuation is (2.07) - (2.77) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 19.6x - 26.3x 23.0x
Forward P/E multiples 16.2x - 26.4x 21.3x
Fair Price (2.07) - (2.77) (2.33)
Upside -235.0% - -281.2% -252.4%
1.53 USD
Stock Price
(2.33) USD
Fair Price

GERN Relative Valuation - Historical P/E Data

Date P/E
2026-08-18 -14.52
2026-08-17 -14.52
2026-08-14 -13.95
2026-08-13 -14.56
2026-08-12 -14.90
2026-08-11 -15.47
2026-08-10 -14.04
2026-08-07 -14.04
2026-08-06 -14.90
2026-08-05 -15.47
2026-08-04 -12.71
2026-08-03 -12.14
2026-07-31 -12.24
2026-07-30 -12.71
2026-07-29 -13.28
2026-07-28 -13.76
2026-07-27 -14.04
2026-07-24 -13.47
2026-07-23 -13.76
2026-07-22 -13.38
2026-07-21 -13.66
2026-07-20 -13.66
2026-07-17 -13.66
2026-07-16 -13.47
2026-07-15 -13.47
2026-07-14 -13.09
2026-07-13 -13.47
2026-07-10 -14.23
2026-07-09 -14.80
2026-07-08 -14.80
2026-07-07 -14.14
2026-07-06 -13.66
2026-07-02 -12.90
2026-07-01 -12.05
2026-06-30 -12.14
2026-06-29 -12.33
2026-06-26 -12.52
2026-06-25 -13.00
2026-06-24 -13.14
2026-06-23 -12.81
2026-06-22 -12.71
2026-06-18 -11.96
2026-06-17 -11.67
2026-06-16 -11.20
2026-06-15 -10.91
2026-06-12 -10.91
2026-06-11 -10.82
2026-06-10 -10.44
2026-06-09 -10.63
2026-06-08 -10.72